Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymergen, Inc. - ZY

09/29/2021 | 10:24pm EST

NEW YORK, Sept. 29, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Zymergen, Inc. ("Zymergen or the "Company") (NASDAQ: ZY). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether Zymergen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On or around April 22, 2021, Zymergen sold approximately 16.3 million shares of stock in its initial public stock offering (the "IPO") at $31.00 per share, raising nearly $505 million in new capital.  Then, on August 3, 2021, Zymergen provided a business update regarding its commercial product pipeline and financial forecast. Zymergen claimed that it recently became aware of issues with its commercial product pipeline that will impact the Company's delivery timeline and revenue projections. As a result, the Company no longer expects product revenue in 2021 and expects product revenue to be immaterial in 2022. Additionally, the Company announced the resignation of Josh Hoffman as Chief Executive Officer and a board member, effective immediately.

Following this news, Zymergen's stock price fell $26.58 per share, or 76.31%, to close at $8.25 per share on August 4, 2021.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

Robert S. Willoughby
Pomerantz LLP
888-476-6529 ext. 7980

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-zymergen-inc---zy-301388388.html

SOURCE Pomerantz LLP

ę PRNewswire 2021
All news about ZYMERGEN INC.
11/22INSIDER BUY : Zymergen
11/15ZYMERGEN INC. Management's Discussion and Analysis of Financial Condition and Results ..
11/11The Law Offices of Frank R. Cruz Announces Investigation of Zymergen Inc. (ZY) on Behal..
11/10Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigati..
11/03ZYMERGEN : Q3 Earnings Snapshot
11/03Zymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business..
11/03Earnings Flash (ZY) ZYMERGEN Reports Q3 Revenue $4.1M, vs. Street Est of $3.41M
11/03Zymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business..
10/26Zymergen to Report Third Quarter 2021 Financial Results on November 3, 2021
10/21ZYMERGEN INC. : Entry into a Material Definitive Agreement, Costs Associated with Exit or ..
More news
Analyst Recommendations on ZYMERGEN INC.
More recommendations